Elizabeth Cermak

Insider Reports History

Entity
Individual
Location
1414 Raleigh Road, Suite 400, Chapel Hill, NC
Signature
/s/ Jonathan Foster by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth Cermak:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Moleculin Biotech, Inc. Director Stock option (right to buy) 14.7K Nov 4, 2024 Direct
Clarus Therapeutics Holdings, Inc. Director Common Stock 5.77K Jun 7, 2022 Direct
Clarus Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 4.81K Jun 7, 2022 Direct

Insider Reports Filed by Elizabeth Cermak

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MBRX Moleculin Biotech, Inc. Nov 4, 2024 1 $0 4 Nov 6, 2024 Director
MBRX Moleculin Biotech, Inc. May 25, 2023 1 $0 4 May 26, 2023 Director
MBRX Moleculin Biotech, Inc. Jun 20, 2022 2 $0 4 Jun 22, 2022 Director
CRXT Clarus Therapeutics Holdings, Inc. Jun 7, 2022 2 $0 4 Jun 9, 2022 Director
CRXT Clarus Therapeutics Holdings, Inc. Dec 12, 2021 2 $0 4 Dec 14, 2021 Director
CRXT Clarus Therapeutics Holdings, Inc. Sep 9, 2021 0 $0 3 Sep 13, 2021 Director
MBRX Moleculin Biotech, Inc. Jun 7, 2021 1 $0 4 Jun 9, 2021 Director